Blocking IL-4Ra with dupilumab prevents lung inflammation in a mouse asthma model

J. Orengo (Tarrytown, United States of America), J. Allinne (Tarrytown, United States of America), A. Le Floc`h (Tarrytown, United States of America), T. Potocky (Tarrytown, United States of America), J. Kim (Tarrytown, United States of America), D. Birchard (Tarrytown, United States of America), G. Scott (Tarrytown, United States of America), Y. Bai (Tarrytown, United States of America), A. Rafique (Tarrytown, United States of America), T. Huang (Tarrytown, United States of America), J. Martin (Tarrytown, United States of America), M. Sleeman (Tarrytown, United States of America), A. Murphy (Tarrytown, United States of America)

Source: International Congress 2018 – Identification of therapeutic targets for asthma
Session: Identification of therapeutic targets for asthma
Session type: Thematic Poster
Number: 977
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Orengo (Tarrytown, United States of America), J. Allinne (Tarrytown, United States of America), A. Le Floc`h (Tarrytown, United States of America), T. Potocky (Tarrytown, United States of America), J. Kim (Tarrytown, United States of America), D. Birchard (Tarrytown, United States of America), G. Scott (Tarrytown, United States of America), Y. Bai (Tarrytown, United States of America), A. Rafique (Tarrytown, United States of America), T. Huang (Tarrytown, United States of America), J. Martin (Tarrytown, United States of America), M. Sleeman (Tarrytown, United States of America), A. Murphy (Tarrytown, United States of America). Blocking IL-4Ra with dupilumab prevents lung inflammation in a mouse asthma model. 977

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: